Unraveling the molecular mechanisms underlying environmental benzophenone-3 exposure and chronic kidney disease

These results demonstrate that BP-3-associated CKD is mediated by a complex interplay between inflammatory and metabolic pathways. Our findings not only offer novel mechanistic insights into how environmental pollutants contribute to CKD pathogenesis but also highlight potential targets for future risk assessment and preventive strategies.